Literature DB >> 25681375

Oral Human Papillomavirus Infection and Oral Lesions in HIV-Positive and HIV-Negative Dental Patients.

Katia Muller1, Julie Kazimiroff2, Mahnaz Fatahzadeh3, Richard V Smith4, Mauricio Wiltz2, Jacqueline Polanco2, Robert M Grossberg5, Thomas J Belbin6, Howard D Strickler7, Robert D Burk8, Nicolas F Schlecht9.   

Abstract

We evaluated the risk factors associated with oral human papillomavirus (HPV) infection and oral lesions in 161 human immunodeficiency virus (HIV)-positive patients and 128 HIV-negative patients presenting for oral examination at 2 urban healthcare centers. Patients were interviewed on risk factors and provided oral-rinse samples for HPV DNA typing by polymerase chain reaction. Statistical associations were assessed by logistic regression. Oral HPV was prevalent in 32% and 16% of HIV-positive patients and HIV-negative patients, respectively, including high-risk HPV type 16 (8% and 2%, respectively; P = .049) and uncommon HPV types 32/42 (6% and 5%, respectively; P = .715). Among HIV-negative patients, significant risk factors for oral HPV included multiple sex partners (≥21 vs ≤5; odds ratio [OR], 9.1; 95% confidence interval [CI], 1.7-49.3), heavy tobacco smoking (>20 pack-years vs none; OR, 9.2; 95% CI, 1.4-59.4), and marijuana use (OR, 4.0; 95% CI, 1.3-12.4). Among HIV-positive patients, lower CD4(+) T-cell count only was associated with oral HPV detection (≤200 vs ≥500 cells/mm(3); OR, 4.5; 95% CI, 1.3-15.5). Detection of high-risk HPV was also associated with concurrent detection of potentially cancerous oral lesions among HIV-negative patients but not among HIV-positive patients. The observed risk factor associations with oral HPV in HIV-negative patients are consistent with sexual transmission and local immunity, whereas in HIV-positive patients, oral HPV detection is strongly associated with low CD4(+) T-cell counts.
© The Author 2015. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  HIV; human papillomavirus (HPV); immunity; oral lesions; sexual activity

Mesh:

Substances:

Year:  2015        PMID: 25681375      PMCID: PMC4539901          DOI: 10.1093/infdis/jiv080

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  32 in total

1.  Effect of highly active antiretroviral therapy on frequency of oral warts.

Authors:  D Greenspan; A J Canchola; L A MacPhail; B Cheikh; J S Greenspan
Journal:  Lancet       Date:  2001-05-05       Impact factor: 79.321

2.  Sexual transmission of oral human papillomavirus infection among men.

Authors:  Kristina R Dahlstrom; Ann N Burchell; Agnihotram V Ramanakumar; Allita Rodrigues; Pierre-Paul Tellier; James Hanley; François Coutlée; Eduardo L Franco
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-11-12       Impact factor: 4.254

3.  Natural history of oral papillomavirus infection in men.

Authors:  Daniel C Beachler; Gypsyamber D'Souza
Journal:  Lancet       Date:  2013-07-02       Impact factor: 79.321

4.  PCR detection of human papillomavirus: comparison between MY09/MY11 and GP5+/GP6+ primer systems.

Authors:  W Qu; G Jiang; Y Cruz; C J Chang; G Y Ho; R S Klein; R D Burk
Journal:  J Clin Microbiol       Date:  1997-06       Impact factor: 5.948

5.  Relationship between prevalent oral and cervical human papillomavirus infections in human immunodeficiency virus-positive and -negative women.

Authors:  Carole Fakhry; Gypsyamber D'souza; Elizabeth Sugar; Kathleen Weber; Eleni Goshu; Howard Minkoff; Rodney Wright; Eric Seaberg; Maura Gillison
Journal:  J Clin Microbiol       Date:  2006-10-04       Impact factor: 5.948

6.  The oral cavity contains abundant known and novel human papillomaviruses from the Betapapillomavirus and Gammapapillomavirus genera.

Authors:  Danielle Bottalico; Zigui Chen; Anne Dunne; Janae Ostoloza; Sharod McKinney; Chang Sun; Nicolas F Schlecht; Mahnaz Fatahzadeh; Rolando Herrero; Mark Schiffman; Robert D Burk
Journal:  J Infect Dis       Date:  2011-09-01       Impact factor: 5.226

7.  Natural history of human papillomavirus infections involving anal, penile, and oral sites among HIV-positive men.

Authors:  Sebastian Videla; Laila Darwich; Mari-Paz Cañadas; Josep Coll; Marta Piñol; Francesc García-Cuyás; Rafael A Molina-Lopez; Patricia Cobarsi; Bonaventura Clotet; Guillem Sirera
Journal:  Sex Transm Dis       Date:  2013-01       Impact factor: 2.830

8.  Comparisons of HPV DNA detection by MY09/11 PCR methods.

Authors:  Philip E Castle; Mark Schiffman; Patti E Gravitt; Hortense Kendall; Stacy Fishman; Huali Dong; Allan Hildesheim; Rolando Herrero; M Concepcion Bratti; Mark E Sherman; Attila Lorincz; John E Schussler; Robert D Burk
Journal:  J Med Virol       Date:  2002-11       Impact factor: 2.327

9.  Novel HPV types present in oral papillomatous lesions from patients with HIV infection.

Authors:  C Völter; Y He; H Delius; A Roy-Burman; J S Greenspan; D Greenspan; E M de Villiers
Journal:  Int J Cancer       Date:  1996-05-16       Impact factor: 7.396

10.  Prevalence, genotype distribution and persistence of human papillomavirus in oral mucosa of women: a six-year follow-up study.

Authors:  Jaana Rautava; Jaana Willberg; Karolina Louvanto; Lilli Wideman; Kari Syrjänen; Seija Grénman; Stina Syrjänen
Journal:  PLoS One       Date:  2012-08-30       Impact factor: 3.240

View more
  3 in total

1.  Oral human papillomavirus prevalence, persistence, and risk-factors in HIV-positive and HIV-negative adults.

Authors:  James Riddell; Andrew F Brouwer; Heather M Walline; Lora P Campredon; Rafael Meza; Marisa C Eisenberg; Emily C Andrus; Rachel L Delinger; Monica L Yost; Jodi K McCloskey; Trey B Thomas; Suiyuan Huang; Robert L Ferris; Dong Moon Shin; Carole Fakhry; Thomas Ow; Daniel Li; Ashley Berlot; Thomas E Carey; Nicolas F Schlecht
Journal:  Tumour Virus Res       Date:  2022-04-20

2.  HIV Modifies the Effect of Tobacco Smoking on Oral Human Papillomavirus Infection.

Authors:  Babatunde Y Alli; Robert D Burk; Mahnaz Fatahzadeh; Julie Kazimiroff; Robert M Grossberg; Richard V Smith; Thomas J Ow; Mauricio Wiltz; Jacqueline Polanco; Marie-Claude Rousseau; Belinda Nicolau; Nicolas F Schlecht
Journal:  J Infect Dis       Date:  2020-07-23       Impact factor: 5.226

Review 3.  Cannabis related side effects in otolaryngology: a scoping review.

Authors:  Jobanjit S Phulka; Joel W Howlett; Amanda Hu
Journal:  J Otolaryngol Head Neck Surg       Date:  2021-09-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.